Upon tumor cell damage or death, DAMPs are released and acquire immunogenicity, capable of binding to pattern recognition receptors such as Toll‐like receptor 4 (TLR4) and the purinergic receptor P2X7, promoting inflammation and activation of the innate immune system. Here, TLR4 is linked to neoplasm.